Siemens Healthineers announced the availability of its molecular Fast Track Diagnostics (FTD) SARS-CoV-2 Assay test kit used to aid in the diagnosis of infection by the SARS-CoV-2 virus that causes the COVID-19 disease. Test kits are already being shipped within the European Union for research use only (RUO) to expedite availability while the company continues to pursue Emergency Use Assessment and Listing (EUAL) from 
Opinion Article by Susan Venables, Founder, Client Services Director, Highland Marketing
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it can help general practitioners and healthcare institutions manage the increased patient flows resulting from the COVID-19 outbreak through a dedicated and scalable telehealth solution that facilitates the use of online screening, follow-up questionnaires and monitoring, and external call center collaborations. 
Buddy Healthcare wants to help hospitals and healthcare professionals in the battle against the COVID-19. BuddyCare virtual care platform can be used for not only symptom tracking, remote monitoring and data collection purposes but also in digitizing secure communication between the individuals/patients and healthcare professionals. Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced that it is increasing the production of certain critical care products and solutions to help diagnose and treat patients with the new coronavirus disease (COVID-19). 
Allscripts (NASDAQ: MDRX) is taking several steps to further its commitment to help fight the global spread of COVID-19. The company is working closely with health agencies and governments around the world to keep abreast of changes and partnering with clients to share and enable their Allscripts solutions to help combat the spread of the virus and manage their patients.